Focus:
News
-
22 February 2020
Coronavirus: A timeline of how the deadly Covid-19 outbreak is evolving
Here's the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and is spreading across the world.
-
21 February 2020
Jack Ma Foundation awards grant to develop drugs against Covid-19
Jack Ma Foundation has awarded a $2.1m grant to four research teams at Columbia University to identify antiviral drugs and antibodies that can be used against the Covid-19 coronavirus.
-
21 February 2020
Vietnam’s Vingroup funds three coronavirus research projects
Vingroup Innovation Foundation (VINIF) is set to fund coronavirus research projects by The Company for Vaccine and Biological Production No.1 (Vabiotech), Pasteur Institute in Ho Chi Minh City and Institute...
-
21 February 2020
SwRI uses screening software to expedite coronavirus research
Southwest Research Institute (SwRI) in the US has leveraged its virtual screening software to speed-up the identification of potential treatments for coronavirus, among other infections.
-
21 February 2020
Tulane University to develop vaccine for novel coronavirus
Tulane University researchers in the US have announced plans to develop a vaccine and diagnostics for the novel coronavirus disease, officially named as COVID-19.
-
21 February 2020
ImmunoPrecise aims to develop coronavirus vaccine and drugs
Canada-based ImmunoPrecise Antibodies has initiated a research programme focused on the development of vaccine and therapeutic antibodies against the coronavirus, SARS-CoV-2.
-
21 February 2020
Beroni Group teams up with Tianjin University for COVID-19 treatment
Australian biopharmaceutical firm Beroni Group has partnered with Tianjin University in China to develop targeted treatment and quick detection technique for COVID-19.
-
21 February 2020
GSK and Immatics partner on cell therapies for cancer
GlaxoSmithKline (GSK) has partnered with Germany-based Immatics Biotechnologies for the development of adoptive cell therapies to treat different cancers.
-
21 February 2020
Favilavir approved as experimental coronavirus drug
Zhejiang Hisun Pharmaceutical’s anti-viral drug Favilavir (Favipiravir) has been approved as an investigational therapy to treat the coronavirus, reported local media.
-
21 February 2020
Coronavirus death toll hits 2,247; China calls for medical workers care
Coronavirus deaths have climbed to 2,247, including 2,236 recorded in Mainland China, as of the end of 20 February. In Hubei province, the total number of deaths stands at 2,144.